Synopsis

Source of validity: Scientific
Rating (out of 5): 2

Peppermint oil has been investigated as a complementary therapy for gastrointestinal disorders, including Inflammatory Bowel Disorders (IBD) such as Crohn’s disease and ulcerative colitis. The primary active component, menthol, is thought to exert antispasmodic effects on the smooth muscle of the gastrointestinal tract through calcium channel blockade. This property helps reduce abdominal pain and cramping, symptoms commonly experienced in IBD. Several randomized controlled trials and meta-analyses have demonstrated the efficacy of enteric-coated peppermint oil capsules in reducing symptoms of irritable bowel syndrome (IBS), a related but distinct condition. However, when it comes to IBD specifically, the evidence is less robust. Most clinical studies focus on IBS, and those that do include IBD patients tend to be small or of low quality, often assessing symptom relief rather than inflammation or disease activity directly. Traditional use of peppermint oil for digestive complaints dates back centuries, but its application in IBD management is relatively recent and largely driven by its success in IBS. Current clinical guidelines do not endorse peppermint oil as a treatment for IBD, though some patients may use it for symptomatic relief of pain or bloating. Overall, while there is a plausible mechanism and some early clinical data, high-quality evidence specifically supporting peppermint oil for IBD is limited, justifying a moderate-low evidence rating.

More about Peppermint
More about Inflammatory Bowel Disorders

Other ingredients used for Inflammatory Bowel Disorders

Other health conditions supported by Peppermint

Products containing Peppermint

Metagenics Intesol® Enteric Coated
Integrative Therapeutics Y Formula